Healthcare Triangle, Inc. will effect a 1-for-20 reverse stock split of its common stock to regain compliance with the Nasdaq Capital Market's $1.00 minimum bid price requirement. The split becomes effective at 12:01 a.m. Eastern Time on Monday, October 26, 2026, with trading on a post-split basis commencing at the market open on that same date, pending confirmation by the Depository Trust Company and Nasdaq.
The Pleasanton, California-based company provides digital transformation solutions, including managed services, cloud enablement, and data analytics for healthcare and life sciences organizations. Under the terms of the split, each twenty shares of issued and outstanding common stock will automatically convert into one share. This action reduces the total number of outstanding shares from approximately 17,730,008 to approximately 886,501. The par value per share remains $0.00001, and the total number of authorized shares remains unchanged.
The company expects the reverse split to increase the price per share of its common stock. Healthcare Triangle's stock will continue to trade on the Nasdaq Capital Market under the existing symbol "HCTI." A new CUSIP number, 42227W 504, has been assigned as a result of the transaction. No fractional shares will be issued; stockholders entitled to a fractional share will receive a rounding up to the next whole post-split share.
Stockholders of record as of October 26, 2026, will receive information regarding their share ownership from VStock Transfer, LLC, the company's transfer agent. VStock Transfer can be reached at (212) 828 8436. Additional details regarding the reverse stock split are available in the company's definitive proxy statement on Schedule 14A, which was filed with the U.S. Securities and Exchange Commission on October 13, 2026. The proxy statement is accessible free of charge at sec.gov.
Healthcare Triangle supports hospitals, health systems, payers, and pharma/life sciences organizations in improving health outcomes through better utilization of data and information technologies. The company holds HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz and DataEz. Its HITRUST Risk-based, 2-year (r2) Certified status indicates adherence to standards for data protection and information security. The firm focuses on digital transformation areas including cloud security, compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization.
The press release includes forward-looking statements regarding the company's expectations for the reverse split and its compliance strategy. These statements involve risks and uncertainties that could cause actual results to differ materially from projections. Investors are directed to read the risk factors set forth in the company's Proxy Statement filed with the SEC on October 13, 2026, as well as previous and future periodic reports. The company makes no guarantee of future performance and undertakes no obligation to revise forward-looking statements after the date of the release.